scholarly journals Potential Impact of 2017 American College of Cardiology / American Heart Association High Blood Pressure Guideline on Chinese Adults---How to Face?

2019 ◽  
Author(s):  
Yundi Jiao ◽  
Zhaoqing Sun ◽  
Yanxia Xie ◽  
Jia Zheng ◽  
Zhao Li ◽  
...  
Keyword(s):  
Blood Pressure ◽  
American Heart Association ◽  
American Heart ◽  
Heart Association ◽  
Intensive Management ◽  
Chinese Adults ◽  
Nutrition Survey ◽  
Health And Nutrition ◽  
Potential Impact ◽  
Crude Prevalence

Abstract Background The current analysis was to estimate the percentage and number of Chinese adults with hypertension and recommended for pharmacological anti-hypertensive treatment according to the 2017 American College of Cardiology / American Heart Association (ACC/AHA) guideline as compared with the 2010 Chinese Guideline.Methods We used the 2011 data of China Health and Nutrition Survey (CHNS). 12,499 Chinese adults aged ≥ 18 years with complete blood pressure (BP) values were selected for the present analysis.Results The crude prevalence (95% CI) of hypertension according to the definitions from 2017 ACC/AHA guideline and the 2010 Chinese guideline was 58.0% (57.2% to 58.9%) and 25.4% (24.7% to 26.2%), respectively. Meanwhile, the percentage of recommended anti-hypertensive medications was 31.5% and 28.8%. Among adults who taking anti-hypertensive medications, the percentage of which had above goal BP level was 88.8% compared to 53.3%. Overall, 613.3 million Chinese adults (aged ≥ 18 years) met the definition for hypertension according to the 2017 ACC/AHA guideline, for which was 267.7 million according to the 2010 Chinese guideline. An additional 28.4 million (2.7%) Chinese adults were recommended anti-hypertensive medication.Conclusions The present analysis revealed that 2017 ACC/AHA hypertension guideline will result in a substantial increase in the percentage and number of Chinese adults defined as having hypertension and a small increase in the percentage of adults who are recommended anti-hypertensive medications compared to the 2010 Chinese guideline. More intensive management and anti-hypertensive medications are suggested to improve the control rate of hypertension among Chinese adults.

scholarly journals Potential Impacts of the 2017 American College of Cardiology / American Heart Association High Blood Pressure Guideline on Chinese Adults and How to Address Them

2020 ◽  
Author(s):  
Yundi Jiao ◽  
Zhaoqing Sun ◽  
Yanxia Xie ◽  
Jia Zheng ◽  
Zhao Li ◽  
...  
Keyword(s):  
Blood Pressure ◽  
American Heart Association ◽  
American Heart ◽  
Heart Association ◽  
Chinese Adults ◽  
Nutrition Survey ◽  
Antihypertensive Medications ◽  
Health And Nutrition ◽  
To Receive ◽  
Crude Prevalence

Abstract Background: The current analysis was performed to estimate the percentage and number of Chinese adults with hypertension and the percentage and number of Chinese adults recommended to receive pharmacological antihypertensive treatment according to the 2017 American College of Cardiology / American Heart Association (ACC/AHA) guideline compared with the same parameters according to the 2010 Chinese guideline. Methods: We use2011 data from the China Health and Nutrition Survey (CHNS). A total of 12,499 Chinese adults aged ≥ 18 years with complete blood pressure (BP) values were selected for the present analysis. Results: The crude prevalence rates (95% CI) of hypertension according to the definitions from the 2017 ACC/AHA guideline and the 2010 Chinese guideline were 58.0% (57.2% to 58.9%) and 25.4% (24.7% to 26.2%), respectively. Moreover, the percentage of the participants recommended to take antihypertensive medications were 31.5% and 28.8%, respectively. Among adults who took antihypertensive medications, 88.8% had above-goal BP levels compared to 53.3%. Overall, 613.3 million Chinese adults (aged ≥ 18 years) met the criteria for hypertension according to the 2017 ACC/AHA guideline, and 267.7 million met the criteria according to 2010 Chinese guideline. An additional 28.4 million (2.7%) Chinese adults were recommended to take antihypertensive medication. Conclusions: The present analysis revealed that the 2017 ACC/AHA hypertension guideline will result in a substantial increase in the percentage and number of Chinese adults defined as having hypertension and a small increase in the percentage of adults who are recommended to take antihypertensive medications compared to the same parameters based on the 2010 Chinese guideline. More intensive management and antihypertensive medications use are suggested to improve the control rate of hypertension among Chinese adults.

scholarly journals Potential Impacts of the 2017 American College of Cardiology / American Heart Association High Blood Pressure Guideline on Chinese Adults and How to Address Them

2020 ◽  
Author(s):  
Yundi Jiao ◽  
Zhaoqing Sun ◽  
Yanxia Xie ◽  
Jia Zheng ◽  
Zhao Li ◽  
...  
Keyword(s):  
Blood Pressure ◽  
American Heart Association ◽  
American Heart ◽  
Heart Association ◽  
Chinese Adults ◽  
Nutrition Survey ◽  
Antihypertensive Medications ◽  
Health And Nutrition ◽  
To Receive ◽  
Crude Prevalence

Abstract Background: The current analysis was performed to estimate the percentage and number of Chinese adults with hypertension and the percentage and number of Chinese adults recommended to receive pharmacological antihypertensive treatment according to the 2017 American College of Cardiology / American Heart Association (ACC/AHA) guideline compared with the same parameters according to the 2010 Chinese guideline. Methods: We use2011 data from the China Health and Nutrition Survey (CHNS). A total of 12,499 Chinese adults aged ≥ 18 years with complete blood pressure (BP) values were selected for the present analysis. Results: The crude prevalence rates (95% CI) of hypertension according to the definitions from the 2017 ACC/AHA guideline and the 2010 Chinese guideline were 58.0% (57.2% to 58.9%) and 25.4% (24.7% to 26.2%), respectively. Moreover, the percentage of the participants recommended to take antihypertensive medications were 31.5% and 28.8%, respectively. Among adults who took antihypertensive medications, 88.8% had above-goal BP levels compared to 53.3%. Overall, 613.3 million Chinese adults (aged ≥ 18 years) met the criteria for hypertension according to the 2017 ACC/AHA guideline, and 267.7 million met the criteria according to 2010 Chinese guideline. An additional 28.4 million (2.7%) Chinese adults were recommended to take antihypertensive medication. Conclusions: The present analysis revealed that the 2017 ACC/AHA hypertension guideline will result in a substantial increase in the percentage and number of Chinese adults defined as having hypertension and a small increase in the percentage of adults who are recommended to take antihypertensive medications compared to the same parameters based on the 2010 Chinese guideline. More intensive management and antihypertensive medications use are suggested to improve the control rate of hypertension among Chinese adults.

scholarly journals A longitudinal analysis of the progression from normal blood pressure to stage 2 hypertension: A 12-year Korean cohort

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Eun Sun Yu ◽  
Kwan Hong ◽  
Byung Chul Chun
Keyword(s):  
Blood Pressure ◽  
Health Insurance ◽  
American Heart Association ◽  
American Heart ◽  
Heart Association ◽  
Normal Blood ◽  
Normal Blood Pressure ◽  
The Mean ◽  
Stage 1

Abstract Background The study aimed to estimate the incidence of and period of progression to stage 2 hypertension from normal blood pressure. Methods We selected a total of 21,172 normotensive individuals between 2003 and 2004 from the National Health Insurance Service-Health Screening and followed them up until 2015. The criteria for blood pressure were based on the American College of Cardiology/American Heart Association 2017 guideline (normal BP: SBP < 120 and DBP < 80 mmHg, elevated BP: SBP 120–129 and DBP < 80 mmHg, stage 1 hypertension: SBP 130–139 or DBP 80–89 mmHg, stage 2 hypertension: SBP ≥140 or DBP ≥ 90 mmHg). We classified the participants into four courses (Course A: normal BP → elevated BP → stage 1 hypertension→ stage 2 hypertension, Course B: normal BP → elevated BP → stage 2 hypertension, Course C: normal BP → stage 1 hypertension → stage 2 hypertension, Course D: normal BP → stage 2 hypertension) according to their progression from normal blood pressure to stage 2 hypertension. Results During the median 12.23 years of follow-up period, 52.8% (n= 11,168) and 23.6% (n=5004) of the participants had stage 1 and stage 2 hypertension, respectively. In particular, over 60 years old had a 2.8-fold higher incidence of stage 2 hypertension than 40–49 years old. After the follow-up period, 77.5% (n=3879) of participants with stage 2 hypertension were found to be course C (n= 2378) and D (n=1501). After the follow-up period, 77.5% (n=3879) of participants with stage 2 hypertension were found to be course C (n= 2378) and D (n=1501). The mean years of progression from normal blood pressure to stage 2 hypertension were 8.7±2.6 years (course A), 6.1±2.9 years (course B), 7.5±2.8 years (course C) and 3.2±2.0 years, respectively. Conclusions This study found that the incidence of hypertension is associated with the progression at each stage. We suggest that the strategies necessary to prevent progression to stage 2 hypertension need to be set differently for each target course.

Sign in / Sign up

Export Citation Format

Share Document